microsimulation markov model Search Results


90
Novartis markov microsimulation model
Characteristics of included studies.
Markov Microsimulation Model, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/markov microsimulation model/product/Novartis
Average 90 stars, based on 1 article reviews
markov microsimulation model - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
treeage software markov state transition patient-level microsimulation model
Characteristics of included studies.
Markov State Transition Patient Level Microsimulation Model, supplied by treeage software, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/markov state transition patient-level microsimulation model/product/treeage software
Average 90 stars, based on 1 article reviews
markov state transition patient-level microsimulation model - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
treeage software markov microsimulation model of asd
Characteristics of included studies.
Markov Microsimulation Model Of Asd, supplied by treeage software, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/markov microsimulation model of asd/product/treeage software
Average 90 stars, based on 1 article reviews
markov microsimulation model of asd - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Characteristics of included studies.

Journal: Osteoporosis and Sarcopenia

Article Title: Systematic evidence of health economic evaluation of drugs for postmenopausal osteoporosis: A quality appraisal

doi: 10.1016/j.afos.2020.05.006

Figure Lengend Snippet: Characteristics of included studies.

Article Snippet: 19 , Hiligsmann [ ], 2010 , Belgium , Potential clinical and economic impact of nonadherence with osteoporosis medications , CEA , Healthcare payer , QALY , Markov microsimulation model , Lifetime , 3%, 1.5% , Novartis.

Techniques: Biomarker Discovery, Medications, Comparison, Injection